Development and validation of an objective method of determining skin erythema to transdermal oestradiol patches

David Ross,M. Whitehead,Barry G. Pike

DOI: https://doi.org/10.1111/j.1471-0528.1999.tb08244.x

1999-03-01

British Journal of Obstetrics and Gynaecology

Abstract:One problem which has limited the acceptance of transdermal oestradiol patches is skin reaction at the site of patch application. The reported incidence ranges up to a maximum of approximately 40%14, with a smaller percentage of women discontinuing therapy. Skin reactions typically consist of erythema and oedema, with more severe reactions such as blistering occumng occasionally. The original patch (Estraderm TTS, Ciba-Geigy, Basel, Switzerland) consisted of a fluid filled reservoir containing oestradiol, covered by a semi-permeable inner membrane and kept in contact with the skin by a ring of adhesive. This was referred to as a ‘reservoir’ patch. Subsequently, the ‘matrix’ patch was developed. This looks quite different and contains oestradiol distributed in adhesive across the whole of the patch surface. Anecdotal and published reports”‘ suggest that the incidence of skin reactions differs between reservoir and matrix patch systems. Any study relying on subjective assessment of skin changes is potentially confounded by observer bias. This can never be excluded in a comparison of vkually dissimilar patches. Therefore we have developed an objective method of measuring patch site skin irritation using photographic digital image analysis.